AMGN34:BVMF
Amgen Inc. BDR
95,99Â BRL
0,00%
(0,00) 1D
16 nën, 5:53:51 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN34...
Hap
96,06Â BRL
I lartë
96,06Â BRL
I ulët
95,41Â BRL
Kapitalizimi i tregut
250,07Â mld
Vëllimi mesatar
615,00
Vëllimi
190,00
Maksimumi 52-javor
96,06Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,91Â mln
Numri i punonjësve
32 mijë
Hap
96,06Â BRL
I lartë
96,06Â BRL
I ulët
95,41Â BRL
Kapitalizimi i tregut
250,07Â mld
Vëllimi mesatar
615,00
Vëllimi
190,00
Maksimumi 52-javor
96,06Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,91Â mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investor's Business Daily
·
18 orë më parë
Dow Jones Biotech Giant Amgen In Buy Zone Amid Ongoing Stock Market Weakness
Trefis
·
1 ditë më parë
Is Amgen Stock Still Telling Investors The Same Thing?
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc. BDR
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
SektoriHealth Care
Industria-
Uebsajtiamgen.com